Literature DB >> 18855878

Epithelial stem cells in corneal regeneration and epidermal gene therapy.

G Pellegrini1, P Rama, F Mavilio, M De Luca.   

Abstract

Regenerative medicine refers to innovative therapies aimed at the permanent restoration of diseased tissues and organs. Regeneration of self-renewing tissues requires specific adult stem cells, which need to be genetically modified to correct inherited genetic diseases. Cultures of epithelial stem cells permanently restore severe skin and mucosal defects, and genetically corrected epidermal stem cells regenerate a normal epidermis in patients carrying junctional epidermolysis bullosa. The keratinocyte stem cell is therefore the only cultured stem cell used both in cell therapy and gene therapy clinical protocols. Epithelial stem cell identification, fate and molecular phenotype have been extensively reviewed, but not in relation to tissue regeneration. In this paper we focus on the localization and molecular characterization of human limbal stem cells in relation to corneal regeneration, and the gene therapy of genetic skin diseases by means of genetically modified epidermal stem cells.

Entities:  

Mesh:

Year:  2009        PMID: 18855878     DOI: 10.1002/path.2441

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  31 in total

1.  Optical coherence tomography as a rapid, accurate, noncontact method of visualizing the palisades of Vogt.

Authors:  Kira L Lathrop; Divya Gupta; Larry Kagemann; Joel S Schuman; Nirmala Sundarraj
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-03-15       Impact factor: 4.799

Review 2.  Gene therapy in the cornea: 2005--present.

Authors:  Rajiv R Mohan; Jonathan C K Tovey; Ajay Sharma; Ashish Tandon
Journal:  Prog Retin Eye Res       Date:  2011-09-28       Impact factor: 21.198

3.  SSEA4 is a potential negative marker for the enrichment of human corneal epithelial stem/progenitor cells.

Authors:  Thuy T Truong; Kyle Huynh; Martin N Nakatsu; Sophie X Deng
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-11       Impact factor: 4.799

Review 4.  From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.

Authors:  Beau R Webber; Jakub Tolar
Journal:  Mol Ther       Date:  2015-03-24       Impact factor: 11.454

5.  Regenerative medicine: An eye to treating blindness.

Authors:  Elena Ezhkova; Elaine Fuchs
Journal:  Nature       Date:  2010-07-29       Impact factor: 49.962

Review 6.  Stem cell therapy: an exercise in patience and prudence.

Authors:  Huan-Ting Lin; Makoto Otsu; Hiromitsu Nakauchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-01-05       Impact factor: 6.237

Review 7.  Mesenchymal stem cells: Potential role in corneal wound repair and transplantation.

Authors:  Fei Li; Shao-Zhen Zhao
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

8.  Corneal goblet cells and their niche: implications for corneal stem cell deficiency.

Authors:  Ahdeah Pajoohesh-Ganji; Sonali Pal-Ghosh; Gauri Tadvalkar; Mary Ann Stepp
Journal:  Stem Cells       Date:  2012-09       Impact factor: 6.277

9.  Expression and localization of epithelial stem cell and differentiation markers in equine skin, eye and hoof.

Authors:  Renata L Linardi; Susan O Megee; Sarah R Mainardi; Makoto Senoo; Hannah L Galantino-Homer
Journal:  Vet Dermatol       Date:  2015-05-12       Impact factor: 1.589

10.  Acellular porcine corneal matrix as a carrier scaffold for cultivating human corneal epithelial cells and fibroblasts in vitro.

Authors:  Ju Zhang; Can-Wei Zhang; Li-Qun Du; Xin-Yi Wu
Journal:  Int J Ophthalmol       Date:  2016-01-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.